Philip Morris International Inc (PM) concluded trading on Wednesday at a closing price of $174.64, with 6.25 million shares of worth about $1.09 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 35.81% during that period and on May 21, 2025 the price saw a gain of about 0.30%. Currently the company’s common shares owned by public are about 1.56B shares, out of which, 1.55B shares are available for trading.
Stock saw a price change of 6.47% in past 5 days and over the past one month there was a price change of 6.42%. Year-to-date (YTD), PM shares are showing a performance of 45.11% which increased to 74.94% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $98.93 but also hit the highest price of $176.49 during that period. The average intraday trading volume for Philip Morris International Inc shares is 6.64 million. The stock is currently trading 2.41% above its 20-day simple moving average (SMA20), while that difference is up 8.08% for SMA50 and it goes to 27.72% higher than SMA200.
Philip Morris International Inc (NYSE: PM) currently have 1.56B outstanding shares and institutions hold larger chunk of about 81.37% of that.
The stock has a current market capitalization of $271.83B and its 3Y-monthly beta is at 0.53. PE ratio of stock for trailing 12 months is 35.89, while it has posted earnings per share of $4.87 in the same period. Its PEG reads 3.18 and has Quick Ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PM, volatility over the week remained 1.58% while standing at 1.78% over the month.
Stock’s fiscal year EPS is expected to rise by 13.65% while it is estimated to increase by 10.77% in next year. EPS is likely to grow at an annualized rate of 11.28% for next 5-years, compared to annual growth of -0.38% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on April 25, 2025 offering a Neutral rating for the stock and assigned a target price of $170 to it. Stock get a Hold rating from Societe Generale on February 13, 2024.